Improving Treatment Adherence and Outcomes in PAH Patients

PROGRAM DESCRIPTION Pulmonary arterial hypertension (PAH) is a rare, chronic condition characterized by pulmonary vascular resistance, remodeling and occlusion of the pulmonary arterioles, right ventricular dysfunction, right heart failure, and ...

PROGRAM DESCRIPTION
Pulmonary arterial hypertension (PAH) is a rare, chronic condition characterized by pulmonary vascular resistance, remodeling and occlusion of the pulmonary arterioles, right ventricular dysfunction, right heart failure, and death, if untreated. Data from the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) has shown that the diagnosis of PAH is often missed or delayed with the average length of time from symptom onset to diagnosis estimated to range from 1 to 3 years. A thorough understanding of the diagnosis, classification and functional status of patients with PAH is essential to selecting the optimum therapy for these patients. The purpose of this activity is to focus on several important aspects of PAH management including a review of the pathophysiology, classification, predictors of disease progression and clinical outcomes of PAH; a discussion of clinical trial data on existing and emerging therapeutics for the management of PAH; and a review of effective strategies to improve therapeutic and clinical outcomes in patients with PAH.

EDUCATIONAL OBJECTIVES
After completing this activity, participants should be able to:Discuss the diagnosis, classification, functional capacity classification, rationale for the use of echocardiography, right heart catheterization (RHC), vasoreactivity testing, and when to referpatients with suspected pulmonary arterial hypertension (PAH) to a specialist centerReview the clinical trial data for existing and emerging therapeutics for the management of pulmonary arterial hypertension (PAH)Identify effective provider-patient communication strategies to improve treatment adherence and outcomes for patients with pulmonary arterial hypertension (PAH)

---

Write the first review

Resource tags